• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Regulatory mechanism of expression of ETS transcription factor Myeloid elf-1-like factor (MEF) by tumor suppressors

Research Project

  • PDF
Project/Area Number 23590082
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Biological pharmacy
Research InstitutionKumamoto University

Principal Investigator

SUICO Mary Ann Soten  熊本大学, 大学院生命科学研究部(薬), 助教 (20363525)

Project Period (FY) 2011 – 2013
Keywords転写因子 / がん抑制遺伝子 / MEF / 低酸素 / HIF1 / ETS転写因子
Research Abstract

Myeloid elf-1-like factor (MEF) functions as transcriptional factor and plays critical roles in development, cellular differentiation, proliferation, transformation and immune responses. In the present study, we aim to determine the regulatory mechanisms of MEF expression by several cellular factors. First, we demonstrated that tumor suppressor p53 decreases the level of MEF protein through the induction of transcription of MDM2, an E3 ubiquitin ligase. Moreover, the findings also revealed that another tumor suppressor Rb increases the MEF protein level possibly by stabilizing its protein expression. Finally, our data further showed that hypoxia increases both the mRNA and protein levels of MEF through HIF1alpha, the main effector molecule of hypoxia. On the whole, the findings revealed in these studies provide a better understanding of how the transcriptional regulator MEF is influenced by tumor suppressors such as p53 and Rb, and by hypoxia-related protein HIF1alpha.

  • Research Products

    (10 results)

All 2014 2013 2012 2011 Other

All Journal Article (2 results) (of which Peer Reviewed: 2 results) Presentation (7 results) Remarks (1 results)

  • [Journal Article] Rb/E2F1 regulates the innate immune receptor Toll-like receptor 3 in epithelial cells2012

    • Author(s)
      Taura M, Suico MA, Koyama K, Komatsu K, Miyakita R, Matsumoto C, Kudo E, Kariya R, Goto H, Kitajima S, Takahashi C, Shuto T, Nakao M, Okada S, Kai H
    • Journal Title

      Mol Cell Biol

      Volume: 32 Pages: 1581-1590

    • DOI

      10.1128/MCB.06454-11

    • Peer Reviewed
  • [Journal Article] MEF/ELF4 transactivation by E2F1 is inhibited by p532011

    • Author(s)
      Taura M, Suico MA, Fukuda R, Koga T, Shuto T, Sato T, Morino-Koga S, Okada S, Kai H
    • Journal Title

      Nucleic Acids Res

      Volume: 39 Pages: 76-88

    • DOI

      10.1093/nar/gkq762

    • Peer Reviewed
  • [Presentation] Functional interplay of p53 and TLR links immune response and cancer2014

    • Author(s)
      Mary Ann SUICO
    • Organizer
      日本薬学会第134年会
    • Place of Presentation
      熊本
    • Year and Date
      20140328-30
  • [Presentation] Specific pulse-width mild electrical stimulation induces p53 activation via p38 MAPK and ameliorates LPS-induced inflammatory cytokine response2013

    • Author(s)
      K. Omachi
    • Organizer
      15th International congress of immunology
    • Place of Presentation
      Milano, ITALY
    • Year and Date
      20130822-27
  • [Presentation] p53 regulates the Ets transcription factor MEF/Elf4 via MDM22012

    • Author(s)
      Mary Ann SUICO
    • Organizer
      ASCB 2012 Annual Meeting
    • Place of Presentation
      San Francisco, USA
    • Year and Date
      20121215-19
  • [Presentation] p53 regulates the Ets transcription factor MEF/Elf4 via MDM22012

    • Author(s)
      Mary Ann SUICO
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      北海道
    • Year and Date
      20120919-21
  • [Presentation] The tumor suppressor Retinoblastoma protein positively regulates innate immune receptor Toll-like receptor 3 in epithelial cells2011

    • Author(s)
      K. Koyama
    • Organizer
      第34回日本分子生物学会年会
    • Place of Presentation
      神奈川
    • Year and Date
      20111213-16
  • [Presentation] Protective effects of p53 in a mouse model of progressive hereditary kidney disease Alport syndrome2011

    • Author(s)
      R. Fukuda
    • Organizer
      ASCB 51st Annual Meeting
    • Place of Presentation
      Denver, USA
    • Year and Date
      20111203-07
  • [Presentation] Mef/Elf4 transactivation by E2F1 is inhibited by p532011

    • Author(s)
      Mary Ann SUICO
    • Organizer
      第70回日本癌学会学術総会
    • Place of Presentation
      名古屋
    • Year and Date
      20111003-05
  • [Remarks]

    • URL

      http://www.molmed730.org/

URL: 

Published: 2015-07-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi